Hyderabad Telangana, India

Shashi Kant Tiwari


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shashi Kant Tiwari: Innovator in Pharmaceutical Processes

Introduction

Shashi Kant Tiwari is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions in the field of pharmaceuticals, particularly through his innovative research and development efforts. His work focuses on the synthesis of essential compounds that have valuable applications in medicine.

Latest Patents

Shashi Kant Tiwari holds a patent for a process concerning the preparation of phenoxybenzamine. The patent outlines a method for producing N-phenoxyisopropyl ethanolamine and its conversion to phenoxybenzamine or its pharmaceutically acceptable salts. This invention not only showcases his expertise but also emphasizes his dedication to enhancing pharmaceutical formulations and therapeutic options.

Career Highlights

Shashi is currently employed at Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His role involves leveraging his knowledge to contribute to the development of innovative solutions that meet healthcare needs.

Collaborations

In his professional journey, Shashi has collaborated with talented colleagues such as Rajesh Chennuri and Bhanuchandar Samala. Their teamwork exemplifies the collaborative spirit necessary for driving innovation and success within the pharmaceutical sector.

Conclusion

Shashi Kant Tiwari continues to be a dynamic force in the realm of pharmaceutical innovations. With his patent standing as a testament to his inventive spirit and dedication, he plays a vital role in elevating the standards of healthcare through scientific advancements. His contributions are not only significant to his company but also to the broader medical community, showcasing the importance of continuous innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…